Integrated DNA Technologies acquires Archer™ next generation sequencing research assays to advance actionable scientific discoveries.

IDT's Virtual Summit | Past, Present, and Future of Whole Exome Sequencing

IDT's Virtual Summit | Past, Present, and Future of Whole Exome Sequencing

Yesterday’s limitations are tomorrow’s opportunities. Contribute to knowledge bases, find signatures, and research elusive new cancer mutations with whole exome sequencing tools by IDT. With the most complete coverage, established quality metrics, and a broad range of customizable solutions, IDT’s whole exome sequencing (WES) solutions offer greater confidence for cancer researchers.

Published on: August 04, 2022

Categories:

Next generation sequencing Methods Targeted DNA Sequencing Targeted RNA Sequencing Whole Exome Sequencing Webinar

*RUO—For research use only. Not for use in diagnostic procedures. Unless otherwise agreed to in writing, IDT does not intend for these products to be used in clinical applications and does not warrant their fitness or suitability for any clinical diagnostic use. Purchaser is solely responsible for all decisions regarding the use of these products and any associated regulatory or legal obligations.